Korean Lepr Bull.  2001 Dec;34(2):23-33.

Study of Serum S-100 Protein in Leprosy Patients

• Jung BC
• Kim SW
• Suh HS
• Kim NH

Abstract

Leprosy is a granulomatous disease primarily affecting the peripheral nerves. The pathogenesis would be related to the cell-mediated response to mycobacterial antigens, metabolic and biochemical change of Schwann cell, circulating demyelinating factors and other autoimmune process. A specific nerve tissue protein, S-100 protein, has been demonstrated in normal nerves and nerve complexes. The stains of S-100 protein in dermal nerves of leprosy patients have been suggested in assessing the presence of nerve damage. We have estimated the concentration of S-100 protein in the sera of 64 leprosy patients(38 lepromatous leprosy, 26 tuberculoid leprosy) and that of 20 normal controls without neurologic disorders by ELISA. The results obtained were as follows: 1. The mean S-100 protein concentration was 0.0042ng/ml in a total of 64 leprosy patients, with 0.0062ng/ml in lepromatous type and 0.018ng/ml in tuberculoid type. The controls showed 0.0017ng/ml. 2. The analysis of age and serum S-100 protein concentration in both types showed lower value in the fifties of tuberculoid type(p<0.05). With the increase of age, mean S-100 protein concentration in both types tended to increase, but there was no significant correlation(p>0.05). 3. The analysis of duration of illness and serum S-100 protein concentration in both types showed higher value in the forties and fifties in lepromatous type(p<0.05). With the increase of duration of illness, mean S-100 protein concentration tended to increase in lepromatous type and slightly decreased in tuberculoid type, but there was no significant correlation(p>0.05). 4. The mean S-100 protein concentration of patients with neurologic symptoms was 0.0577ng/ml, in contrast with 0.0016ng/ml in patients without neurologic symptoms (p<0.05). In conclusion, the measurement of serum S-100 protein would play a potential role of a useful marker of assessing nerve damage in leprosy patients, esp, with neurologic symptoms.

Keyword

Leprosy; Serum S-100 protein

MeSH Terms

Coloring Agents
Enzyme-Linked Immunosorbent Assay
Humans
Leprosy*
Leprosy, Lepromatous
Nerve Tissue
Nervous System Diseases
Neurologic Manifestations
Peripheral Nerves
S100 Proteins*
Coloring Agents
S100 Proteins